Abnormal Villous Morphology Mimicking a Hydatidiform Mole Associated with Paternal Trisomy of Chromosomes 3,7,8 and Unipaternal Disomy of Chromosome 11. by Sebire, NJ et al.
CASE REPORT Open Access
Abnormal villous morphology mimicking a
hydatidiform mole associated with paternal
trisomy of chromosomes 3,7,8 and
unipaternal disomy of chromosome 11
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Abstract
Background: Pregnancies affected by non-molar chromosomal abnormality may sometimes demonstrate abnormal
chorionic villous morphology that is similar to partial hydatidiform mole. Determination of the underlying aetiology
may be difficult in such cases.
Case Presentation: This report describes a case referred to the regional trophoblastic disease unit as a possible
hydatidiform mole that demonstrated both villous dysmorphology and abnormal p57KIP2 expression. Molecular
genotyping revealed that while most chromosomes in the villous tissue were diploid and biparental, chromosomes
3, 7 and 8 were trisomic with an additional paternally derived chromosome. In contrast chromosome 11 showed
uniparental disomy of paternal origin a situation more usually associated with complete hydatidiform moles. This
unusual case highlights that exceptions may occur to the general rules of both histological morphology and
immunoprofile, and that these can be resolved by detailed molecular genetic investigations.
Conclusion: The findings confirm that trisomic pregnancies may demonstrate morphological villous features similar
to hydatidiform mole, and that loss of p57KIP2 expression occurs due to an absence of maternally transcribed genes
on chromosome 11 and can therefore be independent of androgenetic complete hydatidiform mole.
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Background
Hydatidiform moles (HM) are chromosomally abnormal
pregnancies, characterised by relative overexpression of pa-
ternally derived genes, with abnormal chorionic villi and
villous trophoblastic hyperplasia. Most HM are classified as
complete HM (CHM) or partial HM (PHM), CHM being
androgenetic diploid conceptions and PHM diandric trip-
loids [1]. The diagnosis of CHM and PHM is usually based
on histopathological examination of products of conception
but, in around 10% of cases, such morphological findings
may be non-diagnostic and ancillary investigations are re-
quired, including immunostaining and molecular genotyp-
ing [2–4]. The combination of villous dysmorphology with
absent chorionic villous expression of p57KIP2 usually repre-
sents early CHM [5]. This report describes an unusual case
with villous dysmorphology and negative p57KIP2 staining
of villous cytotrophoblast and stroma in which the under-
lying diagnosis was triple trisomy with paternal uniparental
disomy for chromosome 11. This case highlights both the
clinical utility of molecular genotyping in this setting and
furthermore provides confirmation of a mechanism for loss
of p57KIP2 expression in non-molar gestations.
Case presentation
Clinical details
The patient was a 36 year-old female, G4P1, having had
a normal live birth and two miscarriages. An ultrasound
scan at 12 weeks gestation showed no embryo and raised
the possibility of hydatidiform mole. Following evacu-
ation of retained products of conception for a missed
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miscarriage, the patient was referred to the Trophoblastic
Tumour and Screening Centre at Charing Cross Hospital
with a provisional diagnosis of molar pregnancy. The pa-
tient’s serum hCG had reached normal by the time of
registration and she remains well with no evidence of per-
sistent trophoblastic neoplasia, delivering a healthy baby
boy 29 months after referral to the centre.
Histopathological examination
Routine haematoxylin and eosin (H&E) stained 4 μm sec-
tions were reviewed, using published criteria for distinguish-
ing PHM and CHM from non-molar miscarriage [6–8], by a
specialist trophoblastic disease pathologist with more than
15 years experience in this field. Unstained 4 μm sections
were immunostained using a mouse monoclonal primary
antibody against p57KIP2 (Leica Biosystems, Newcastle) at a
dilution of 1 in 50, and visualised using the Bond Polymer
Refine Detection kit (Leica Biosystems, Newcastle) according
to a standard protocol in a CPA approved diagnostic labora-
tory. Histological review demonstrated villous development
consistent with early second trimester but with marked vil-
lous dysmorphic features, including variation in size and
shape, irregular villous outlines with pseudoinclusions and
patchy villous hydropic change closely mimicking hydatidi-
formmole but morphologically not diagnostic of either PHM
or CHM. These changes were variable from field to field, with
some more normal appearing villi and other areas with more
prominent dysmorphism (Fig. 1). There was limited circum-
ferential trophoblast hyperplasia relative to the degree of
villous dysmorphism and no definite karyorrhexis was identi-
fied. The morphological differential diagnosis was between a
HM and villous dysmorphism secondary to chromosomal ab-
normality. In view of the unusual morphology in this case, an-
cillary studies were undertaken including p57KIP2
immunostaining and molecular genotyping. P57KIP2 immu-
nostaining showed normal strong nuclear expression in extra-
villous trophoblast fragments and decidua but with negative
staining of villous cytotrophoblast and stroma (Fig. 1).
Molecular genotyping
Initially five areas of placental tissue and a single area of mater-
nal decidua were microdissected from formalin-fixed, paraffin-
embedded (FFPE) pathological sections, with reference to a
stained H&E section. DNAwas then prepared from each sam-
ple using a QIAmp DNA FFPE Tissue Kit (Qiagen, Sussex,
UK). DNA was subsequently prepared from 500 μl of paternal
saliva using an Oragene DNA collection kit (DNA Genotek,
Ontario, Canada). 1 μl DNA from the patient, her partner and
villous tissue was amplified with primers for 15 short tandem
repeat (STR) loci on 13 chromosomes, together with the ame-
logenin locus, using an AmpFlSTR Identifiler Plus kit (Applied
Biosystems, Warrington, UK). PCR products were resolved by
capillary electrophoresis using an ABI 3100 Genetic Analyser
and genotypes determined using GeneMapper version 4.0 soft-
ware (Applied Biosystems, Warrington, UK). In order to con-
firm the results obtained using the AmpFlSTR kit, and to
investigate the origin of other chromosomes not represented in
the kit, a panel of markers including STRs located on each
Fig. 1 Photomicrographs of villous tissue showing haematoxylin and eosin staining and p57KIP2 immunostaining. a and b; (haematoxylin and
eosin original magnification x40) demonstrate villous dysmorphism within the spectrum of that seen in molar pregnancies but not typical of
complete or partial hydatidiform mole. c and d; (original magnification x100, immunostained with avidin-biotin detection system and haemtoxylin
counterstain) show associated absence of villous p57KIP2 expression
Sebire et al. Diagnostic Pathology  (2016) 11:20 Page 2 of 8
chromosome was used to amplify DNA from the parental and
placental samples, followed by analysis as described above.
Fluorescent microsatellite genotyping of DNA from the
parents and villous tissue, using the AmpFlSTR kit, revealed
an unusual, but consistent, genotype in all DNA samples
from the villous tissue (Table 1). Loci on chromosomes 3, 7,
and 8 were trisomic, having three different alleles (D8S1179)
or two alleles with one present at twice the dosage of the
other (D3S1358; D7S820) (Fig. 2). Loci on chromosome 7
and 8 both had a single maternally derived allele and two al-
leles from the father while alleles at the D3S1358 locus were
not informative with respect to origin. Six informative loci
on chromosomes 4, 5, 12, 16 and 18 (Table 1; Fig. 2) exhib-
ited equal parental contributions. Allele sizes for loci on 4 of
the remaining chromosomes were consistent with an equal
contribution from each parent (Table 1). However, the
THO1 locus on chromosome 11 was androgenetic, having a
single paternally derived allele (Fig. 2). There was no evi-
dence of mosaicism in the tissue, the genotype of the villi
being identical in all five areas of tissue examined. Further
amplification with primers for STR loci on chromosomes 3,
7 and 8 confirmed trisomy for both the long and short arms
of each chromosome and that the additional chromosome
in each case was paternal in origin (Table 2). Amplification
with primers for STR loci on the remaining autosomes and
the X chromosome were consistent with an equal maternal
and paternal contribution to the genome with the exception
of chromosome 11. An absence of maternal alleles for six in-
formative loci (Table 2) confirmed that the tissue was andro-
genetic for chromosome 11. While 4 loci were homozygous
for a single paternal allele, the D11S569 and D11S934 loci
were heterozygous demonstrating the involvement of two
paternal copies of chromosome 11. The villous tissue there-
fore exhibited paternal disomy for chromosome 3, 7, 8 and
11 together with loss of maternal chromosome 11.
Fluorescence in situ hybridisation
In order to confirm the observations resulting from geno-
typing, fluorescence in situ hybridization (FISH) was per-
formed on sections of the villous tissue. FFPE sections of
the placental tissue were pretreated and hybridized using
the ThermoBrite Elite according to manufacturer’s proto-
cols (Leica Biosystems, Nussloch, Germany). FISH was then
performed using a panel of DNA probes for chromosomes
3 (MECOM; 3q26), 7 (7q22 & 7q36), 8 (MYC; 8q24), 11
(KMT2A; 11q23), 19 (ERCC1; 19q13 & ZNF443; 19p13)
and the X chromosome (DXZ1); all probes were from Krea-
tech (Leica Biosystems). Sections were analysed and focus
stacked images were captured using the Isis imaging system
(MetaSystems, Altlussheim, Germany), again, with refer-
ence to a stained H&E section. Hybridization with probes
for chromosome 3, 7 and 8 confirmed trisomy for each of
these chromosomes. Probes for the X chromosome,
chromosome 19 and chromosome 11 supported the obser-
vation that other chromosomes were disomic (Fig. 3).
Discussion
This case represents an unusual case of pregnancy fail-
ure associated with HM-like villous dysmorphism and a
Table 1 Genotypes of parental and villous tissue for loci amplified by the AmpFlSTR kit
Locus chr Patient Villi Partner Ploidy Parental contributions
D8S1179 8 10 - 12 12 < 14 11 - 14 3n M,P2,P2
D21S11 21 28 - 30 28 28 - 30 NI NI
D7S820 7 9 - 11 8 - 9 - 12 8 - 12 3n M,P1,P2
CSF1PO 5 10 - 11 10 - 12 11 - 12 2n M,P
D3S1358 3 15 - 18 15 > 18 15 - 16 3n NI
THO1 11 6 - 9.3 8 7 - 8 NI P
D13S317 13 11 - 12 11 - 12 11 2n NI
D16S539 16 13 11 - 13 11 2n M,P
D2S1338 2 19 - 23 19 - 23 23 - 24 2n NI
D19S433 19 14 - 15 14 14 - 15 NI NI
vWA 12 17 - 18 16 - 18 16 2n M,P
TPOX 2 8 - 11 8 - 11 8 2n NI
D18S51 18 13 - 14 13 - 19 13 - 17 2n M,P
AMEL X X XY NI NI
D5S818 5 12 - 14 11 - 14 11 2n M,P
FGA 4 21 - 28 21 - 22 22 - 24 2n M,P
Alleles are numbered by comparison with the allelic ladder provided. chr, chromosome; M, maternal allele; P, paternal allele; P1, and P2, smaller and larger
paternal allele respectively; NI, not informative
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complex triple trisomy and paternal uniparental disomy
identified on molecular genotyping studies.
Following early pregnancy failure it is recommended
by the Royal College of Obstetricians and Gynaecologists
Guidelines [9] that all products of conception are examined
histologically since HM cannot be excluded using clinical
or sonographic features alone. The presence of villous
dysmorphic features including variably sized villi, with
patchy hydropic changes, irregular villous outlines and
trophoblastic pseudoinclusions in the present case raised
a b c
d e f
Fig. 2 Partial genotypes of the patient, her partner and the villous tissue. a, b and c show genotypes in the parents and villous tissue following
amplification of STR loci D3S1358, D7S820 and D8S1179 respectively. Trisomy of the villous tissue at these loci is demonstrated by the presence
of two paternal alleles (c) or an increased dosage of a single paternal allele relative to the maternally derived allele (a, b). d shows an example of
a disomic locus with one maternal and one paternal allele, found for loci on the majority of chromosomes. e and f represent loci on chromosome 11
for which the villous tissue has only paternally derived alleles
Sebire et al. Diagnostic Pathology  (2016) 11:20 Page 4 of 8
the possibility of HM and prompted referral to the re-
gional trophoblastic disease centre. Following histological
review villous dysmorphology was confirmed but the mor-
phological findings were not diagnostic for PHM or CHM
and hence ancillary studies were undertaken.
Immunostaining of p57KIP2, the product of the pater-
nally imprinted gene, CDKN1C, shows positive staining
of the cytotrophoblast and villous stroma in all pregnan-
cies except for CHM, in which both sets of chromo-
somes are paternally derived [5], and is thus a useful
discriminator in the diagnosis of CHM [3, 5, 10]. How-
ever, p57KIP2 immunostaining does not discriminate be-
tween PHM and non-molar miscarriages. In this setting,
molecular genotyping to assist definite diagnosis in cases
of suspected gestational trophoblastic disease is now
well-reported in clinical practice, either routinely or in
selected cases [2–4, 11].
In the present case p57KIP2 immunostaining was uni-
formly negative in the cytotrophoblast and villous
stroma suggesting lack of maternal allele expression, as
seen most commonly with CHM. Initial genotyping
using the AmpFlSTR Identifiler Plus kit showed the
tissue to have only a single paternally derived allele for
chromosome 11, the chromosome on which the CDKN1C
gene is located. However, genotyping also demonstrated a
normal diploid origin for most other chromosomal pairs
with the exception of 3, 7 and 8 for which three alleles
were present. FISH was performed to confirm that this
was a diploid conception with triple trisomy, rather than a
tetraploid with loss of chromosomes 3, 7 and 8. FISH
Table 2 Genotypes of parental and villous tissue for additional STR loci
Locus chr Patient Villi Partner Ploidy Parental contributions
Trisomic chromosomes
D3S1300 3p 165 - 169 165 < 181 175 - 181 3n M,P2,P2
D3S1314 3q 68 - 80 68 < 78 78 - 88 3n M,P1,P1
D7S513 7p 152 136 - 140 - 152 136 - 140 3n M,P1,P2
D7S669 7q 126 118 - 124 - 126 118 - 124 3n M,P1,P2
D8S1786 8p 106 106 - 110 -116 110 - 116 3n M,P1,P2
D8S1110 8q 270 - 274 258 - 270 - 274 258 - 270 3n M,P1,P2
Disomic chromosome pairs with a maternal and paternal contribution
D1S1656 1 136 - 161 141 - 161 141 - 150 2n M,P
D2S1391 2 118 - 122 106 - 122 106 - 126 2n M,P
F13A1 6 283 - 287 279 - 283 279 - 287 2n M,P
D9S171 9 165 - 173 163 - 173 157 - 163 2n M,P
D10S189 10 180 - 186 178 - 180 178 - 184 2n M,P
D13S158 13 122 116 - 122 116 NI M,P
D14S51 14 93 - 95 95 - 99 93 - 99 2n M,P
D15S125 15 123 - 129 129 - 131 131 - 133 2n M,P
D17S799 17 184 184 - 190 190 NI M,P
D19S221 19 198 - 206 194 - 206 192 - 194 2n M,P
D20S481 20 231 219 - 231 219 - 235 2n M,P
D21S167 21 160 - 177 160 - 179 175 - 179 2n M,P
D22S264 22 186 - 196 196 - 204 194 - 204 2n M,P
DXS451 X 188 174 - 188 174 NI M,P
Chromosome 11
D11S922 11p 234 - 244 215 215 - 234 NI P1
D11S2071 11p 170 - 189 194 166 - 194 NI P2
D11S569 11p 137 - 146 144 - 148 144 - 148 2n P1,P2
D11S916 11q 170 - 184 172 172 NI P1
D11S925 11q 289 268 268 NI P1
D11S934 11q 274 - 276 278 - 286 278 - 286 2n P1,P2
Allele sizes are given in base pairs. chr, chromosome; M, maternal allele; P, paternal allele; P1, and P2, smaller and larger paternal allele respectively;
NI, not informative
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confirmed the presence of 3 copies of chromosomes 3, 7,
and 8 and two copies of other chromosomes including
chromosome 11. Analysis of additional STR markers on
chromosome 11 confirmed that both copies were paternal
in origin.
Loss or gain of maternal chromosome 11 has previ-
ously been shown to account for unexpected p57KIP2 ex-
pression in molar tissue. Two cases of CHM with
expression of p57KIP2 due to retention of a maternally
derived chromosome 11 have been described [12, 13], in
addition to two PHM in which no expression of p57KIP2
was found in either cytotrophoblast or villous stroma due
to loss of the maternal copy of chromosome 11 [3, 14].
Two interesting cases of mosaic PHM have also been re-
ported in which loss of chromosome 11, identified by
FISH, was seen in the villous stroma of one and the cyto-
trophoblast of the other with corresponding loss of
p57KIP2 expression [15]. However, these PHM cases differ
from the present study in that, they were triploid concep-
tions with loss of chromosome 11 while in the present
case most chromosome pairs were diploid and biparental.
Abnormal villous morphology, with aberrant p57KIP2
and a diploid and biparental genotype is often associated
with the rare inherited condition familial recurrent hydati-
diform mole [16, 17] in which affected women have a pre-
disposition to CHM. However, in the present case the
pathology was not typical of a CHM and three chromo-
somes were shown to be trisomic rather than disomic.
Trisomy, in an otherwise diploid conception, usually re-
sults from meiotic nondisjunction during oogenesis, and
is associated with increased maternal age [18]. Double and
triple trisomies are rare, triple trisomy accounting for only
approximately 0.05% of spontaneous abortions [19]. While
triple trisomy involving chromosomes 13, 16, and 21 has
been described in tissue from two cases of spontaneous
abortion with a differential diagnosis of HM, the parental
origin of the chromosomes was not determined [2, 10].
To our knowledge the only other case of triple trisomy of
paternal origin previously reported occurred in material
from a spontaneous abortion that showed morphological
features of a PHM [20]. However, the previous case dif-
fered to that in the present study in several respects.
While both cases involved trisomy of chromosome 7, the
present case involves chromosomes 3, and 8, rather than
trisomy of 13 and 20. Secondly, the triple trisomy is likely
to have arisen by a different mechanism in each case. In
the previous case homozygosity for paternal alleles, sug-
gested an error at paternal meiosis II or mitotic non-
disjunction. In the present case genotyping for several
STR loci revealed heterozygosity for some, but not all, pa-
ternal alleles, making an error at paternal meiosis I a more
likely origin for the additional paternal chromosomes. Fi-
nally the present case involves paternal disomy for four,
rather than three, paternal chromosomes and loss of the
maternal chromosome 11 resulting in loss of p57KIP2 ex-
pression associated with the otherwise similar villous
dysmorphic features.
The majority of CHM and PHM are associated with
the presence of two copies of the paternal genome.
However, duplication of the entire genome is unlikely to
be necessary for the development of the morphological
features of HM. Studies of cases with unusual genetic
Fig. 3 Interphase FISH analysis of representative villous cells. Probes for chromosomes 3, 7, and 8 (top panel) show one additional signal,
consistent with trisomy for these chromosomes. Probes for chromosomes 11, 19 and X (lower panel) showed two signals only, consistent with
disomy 11 and 19, and a female sex chromosome complement
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constitutions may enable the correlation of different
chromosomal abnormalities to specific morphological
features of molar pregnancies. It has previously been
suggested that trisomy of chromosome 13 is associated
with some features of HM seen on ultrasound [21–23].
However, trophoblastic hyperplasia was not found in
these cases on morphological examination. Other studies
have shown certain chromosomal trisomies, specifically
7 and 15 to show trophoblastic hyperplasia similar to
that seen in HM irrespective of parental origin [24]. This
is of interest given that trisomy of chromosome 7 was
present in both this and the previous case of triple tri-
somy and that trisomy of chromosome 7 is frequently
found in series where genotyping has been performed to
aid in the differential diagnosis of products of concep-
tion [2, 11] or differential diagnosis of PHM [4, 10].
Other trisomies found in these series include trisomy for
16 and 21, the commonest trisomies in both the two lar-
ger series, and trisomy 8,13,18, and X. However, data
from these studies is limited to those chromosomes for
which markers are included in the kits used for genotyp-
ing and some more complex genotypes may be missed.
In our study further STR markers were used to investi-
gate the origin of the long and short arm of all chromo-
somes to demonstrate that chromosomal gain and loss
involved the whole chromosome and identify any other
chromosomal abnormalities that would not have been
identified by the AmpflSTR kit alone. Further studies
that include analysis of all chromosomal regions are
needed to correlate specific genetic change with recog-
nised pathological abnormalities.
Conclusions
This case demonstrates several important issues regard-
ing both pathogenesis of disease and clinical practice.
First, we confirm that trisomic conceptions may demon-
strate villous dysmorphic features, which are similar to
CHM and PHM. Secondly, we demonstrate that absent
p57KIP2 immunostaining indicates loss of maternal gene
expression from the p57KIP2 region on chromosome 11,
rather than CHM. Finally, we confirm the diagnostic im-
portance of selective molecular genetic testing for provid-
ing definitive diagnosis in cases of possible HM in which
morphological features are non-diagnostic. Whilst routine
use of molecular genetic testing is not financially viable
for large publically funded services [4], increasing use of
molecular genetic testing in clinical practice, in relation
to detailed morphological and immunohistochemical
findings, will increase our understanding of genotype-
phenotype relationships in abnormal pregnancies.
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